Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MedLearn Unveils DrugCode Pro: The Ultimate Infusion & Injection Coding Companion


News provided by

Medlearn Media

Apr 04, 2025, 09:00 ET

Share this article

Share toX

Share this article

Share toX

MedLearn empowers professionals with a new tool, DrugCode Pro, an innovative web-based solution designed to streamline infusion and injection drug administration coding.

INVER GROVE HEIGHTS, Minn., April 4, 2025 /PRNewswire-PRWeb/ -- MedLearn is proud to empower professionals with a new tool found nowhere else, DrugCode Pro, an innovative web-based solution designed to streamline infusion and injection drug administration coding. With the end of CMS Table of Drugs era in 2020, coders and charge capture specialists face escalating challenges in accurately assigning HCPCS codes, validating dosages, and ensuring compliance with CMS guidelines. Our exclusive, expertly crafted, DrugCode Pro eliminates the guesswork, reducing claim denials, compliance risks, and lost revenue while electrifying confidence in everyday operations.

An Evolutionary Fast-Track Tool for Drug Administration Coding

DrugCode Pro provides a comprehensive, easy-to-use searchable resource that simplifies coding for infusion and injection drug services. This powerful tool allows users to quickly cross-reference drug names, HCPCS codes, dosages, routes of administration, and modifier requirements (JW/JZ). With up-to-date information at their fingertips, professionals can confidently validate billing units, resolve claim denials, and maintain compliance with CMS regulations.

Five Keyways DrugCode Pro Empowers Coders and Charge Capture Specialists:

  1. Accurate Code Assignment – Validate HCPCS codes, dosages, and administration routes with ease.
  2. Streamlined Workflow – Save time with an intuitive web-based lookup tool.
  3. Compliance Assurance – Stay current with CMS Quarterly Update files and FDA drug data.
  4. Claim Denial Resolution – Verify JW/JZ modifier requirements and Medically Unlikely Edits (MUEs).
  5. Confidence in Coding – Reduce errors and improve accuracy with reliable, real-time updates.

According to nationally renowned subject matter expert, Tiffani Bouchard, CCS, CRCR Revenue Integrity, "Professional charge capture specialists, drug administration services coders, HIM coding managers/directors, and drug administration auditing professionals have access to the lookup tool from wherever they are working (office, cubicle, remote, etc.). During their workday, whether performing charge capture or working on claim denials, they can perform the following:

  • Identify the dosage for a drug HCPCS code to determine or validate billing units.
  • Look up the common route of administration to determine the base injection or infusion drug administration code.
  • Check for brand vs. generic drug names (or manufacturer, where applicable) to validate the assigned code.
  • Verify whether the HCPCS code for the administered drug(s) requires a JW or JZ modifier.
  • Confirm the applicable date range for the HCPCS code to update charge capture and billing.
  • Explore applicable drug administration code(s) or code sets associated with the drug used.
  • Check for drug NDCs published by CMS to determine if a drug is packaged as single-dose/single-use."

"Many coders, charge capture specialists, and pharmacy staff have used the CMS Table of Drugs since it was published and maintained by the agency and allowed open access" states Bouchard, "These individuals have had to find other sources for their daily use. Because some resources and subscriptions can be cost-prohibitive, individuals are relying on less reliable information to monitor drug HCPCS coding and unit validation, which, in turn, increases risk and non-compliance… This resource can be used by novice and advanced professionals to quickly verify the coding associated with the administration of a drug or drugs. Allows ease of validating use of a drug HCPCS code and accuracy of assignment."

Discover the Future of Coding Today

DrugCode Pro is updated quarterly to reflect the latest CMS changes, ensuring users always have access to the most current information. By subscribing to DrugCode Pro, professionals harness a powerful companion for optimizing their workflow and achieving coding excellence.

For more information or to subscribe, visit our website or contact Customer Support at [email protected].

About MedLearn Media

MedLearn is a trusted leader in healthcare coding and compliance solutions, dedicated to helping professionals navigate complex regulations with ease. Through our brands, including MedLearn Publishing, RACmonitor, and ICD10monitor, we deliver cutting-edge resources to help providers navigate complex regulatory, coding, and compliance challenges.

Media Contact

Laura Baker, Medlearn Media, 1 6512923421, [email protected], medlearnmedia.com

SOURCE Medlearn Media

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.